BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, VEGFA, nitric oxide metabolic process, Diabetes mellitus, Kidney)
Bookmark Forward

QuickView for MYPT1;jsessionid=D450FDDBB3E3E6F2ECBA0534AE53EFD4;jsessionid=8B2DB8E9D117B1F8334881328809F0DD;jsessionid=54885D08191FDA60346C1499ACF1AD3F (gene)


Body Atlas

Most Correlated Tissues

  1. Saphenous vein
  2. Basophil of peripheral blood
  3. Eosinophil of peripheral blood
  4. Neutrophil of bone marrow
  5. Leukocyte (polymorphonuclear) of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Caseating tuberculoid granuloma
  2. Pyloric ulcer
  3. Disorder affecting transplanted structure
  4. Infection by Nippostrongylus
  5. Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. velnacrine
  2. arsenate
  3. fipexide
  4. moroxydine
  5. diloxanide furoate
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Htt
  2. FAM198B
  3. CCT8
  4. MGMT
  5. HDAC4
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MYPT1 reduction is a pathogenic factor of erectile dysfunction.
  2. O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid-induced cell contraction in fibroblas…
  3. MYPT1/PP1-Mediated EZH2 Dephosphorylation at S21 Promotes Epithelial-Mesenchymal Transition in Fibro…
  4. MYPT1 O-GlcNAc modification regulates sphingosine-1-phosphate mediated contraction.
  5. Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for MYPT1;jsessionid=D450FDDBB3E3E6F2ECBA0534AE53EFD4;jsessionid=8B2DB8E9D117B1F8334881328809F0DD;jsessionid=54885D08191FDA60346C1499ACF1AD3F
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.